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ABSTRACT
Targeted disruptions of the mouse genes for cytokines, cytokine receptors, or components of cytokine signal-
ing cascades convincingly revealed the important roles of these molecules in immunologic processes. Cyto-
kines are used at present as drugs to fight chronic microbial infections and cancer in humans, and they are
being evaluated as immune response modifiers to improve vaccines. Until recently, only a few avian cytokines
have been characterized, and potential applications thus have remained limited to mammals. Classic ap-
proaches to identify cytokine genes in birds proved difficult because sequence conservation is generally low.
As new technology and high throughput sequencing became available, this situation changed quickly. We re-
view here recent work that led to the identification of genes for the avian homologs of interferon-a/b (IFN-
a/b) and IFN-g, various interleukins (IL), and several chemokines. From the initial data on the biochemical
properties of these molecules, a picture is emerging that shows that avian and mammalian cytokines may per-
form similar tasks, although their primary structures in most cases are remarkably different.
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INTRODUCTION
OVER THE LAST 20 YEARS, it became increasingly clear thatcytokines are central regulators of the immune system.
Whereas a growing number of these molecules were cloned and
functionally characterized in mammals, knowledge of avian cy-
tokines lagged far behind. A strong interest in these im-
munoregulatory molecules in birds arose from different lines of
research. Lack of appropriate growth factors to maintain
chicken T cell cultures and to generate antigen-specific T cell
clones initially stimulated work on the chicken homolog of in-
terleukin-2 (IL-2). More recently, researchers investigating in-
fectious diseases in poultry became interested in the regulation
of immune responses. In particular, the question whether Th1-
type or Th2-type immune responses can be defined in the
chicken became a major focus of discussion. With the cloning
of interferon-g (IFN-g) and IL-18, as well as a number of proin-
flammatory cytokines, the existence of a Th1-like cytokine net-
work could be demonstrated, although firm evidence for Th2
responses in birds is still missing.
The availability of recombinant cytokines and methods to
express cytokines in birds initiated work on their potential use
as immune response modifiers to stimulate innate immunity or
as immune adjuvants to enhance the efficacy of vaccines. This
knowledge is now used increasingly to investigate well-estab-
lished disease models, including Rous sarcoma virus-induced
tumors, the duck model for hepatitis B, several infectious dis-
eases (Marek’s disease, Newcastle disease, salmonellosis and
coccidiosis), as well as autoimmune disease models (Hashimoto
thyroiditis, scleroderma, autoimmune vitiligo).
Here, we review recent work on chicken IFN, IL, and
chemokines. With the exception of chicken myelomonocytic
growth factor, hematopoietic growth factors are not covered in
this paper. For a recent review on these molecules, the reader
is referred to Siatskas and Boyd.(1)
AVIAN CYTOKINE GENES AND THEIR
PRODUCTS
Interferons
Type I IFN. From a historical point of view, the type I IFN
of chickens occupies a privileged position in cytokine research,
as it was the first IFN to be discovered. Isaacs and Linden-
mann(2) discovered it during their seminal studies on a previ-
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ously unknown soluble factor that interfered with influenza A
virus replication in allantoic membranes from embryonated
eggs. It was only after IFN from mammals had been charac-
terized at the molecular level that biochemical procedures be-
came available that, for the first time, yielded substantial
amounts of purified chicken IFN (ChIFN) from virus-induced
embryonated chicken eggs(3) and virus-induced embryonic
chicken cells.(4,5) Purified type I ChIFN was found to be a gly-
coprotein of approximately 25 kDa whose antiviral activity
showed a remarkably high degree of resistance to acid treat-
ment and exposure to heat. These biochemical properties con-
trasted with those of another factor with antiviral activity se-
creted by concanavalin A (ConA)-treated chicken spleen
cells,(6) which was known as type II ChIFN, now referred to as
IFN-g.
The first cDNA for type I ChIFN was identified by Sekel-
lick et al.(7) by an RT-PCR approach in which mRNA from
virus-induced chicken embryo cells was analyzed with primers
from conserved regions of mammalian IFN-a and IFN-b genes.
The protein encoded by this novel chicken gene showed a barely
significant degree of similarity to mammalian IFN-a and IFN-
b (,25% identity at amino acid level). As the precise rela-
tionship of this molecule to the various mammalian type I IFN
was not immediately clear,(8) it was initially designated
“chicken IFN1” by some authors.(9,10) Recent functional stud-
ies indicate that it most likely represents the functional homolog
of mammalian IFN-a.(11) Subsequent work revealed the exis-
tence of about 10 closely related intronless IFN-a genes (Table
1) in the chicken that form a cluster(9) on the short arm of the
chicken Z chromosome.(12) The primary translation product of
ChIFN-a mRNA is a 193-residue polypeptide of which the N-
terminal 31 amino acids seem to represent a signal peptide. Se-
creted ChIFN-a (molecular mass , 19,000) contains four po-
tential N-linked glycosylation sites. Recombinant ChIFN-a
(rChIFN-a) produced in either COS cells or Escherichia coli
is a potent antiviral agent that has a specific activity of about
108 U/mg protein,(13) a value comparable to that of human IFN-
a2.
Low-stringency hybridization of recombinant lambda phages
resulted in the identification of a chicken DNA fragment that
carries an additional intronless type I IFN gene whose product
was only 57% identical to ChIFN-a and ,25% identical to
mammalian IFN.(9) Functional studies indicate that this gene,
initially designated “chicken IFN2” by some authors,(9,10) most
likely codes for the chicken homolog of mammalian IFN-b(11)
(Table 1). The primary translation product of ChIFN-b mRNA
consists of 203 amino acids, including a 28-residue signal pep-
tide. Thus, secreted ChIFN-b is 14 residues longer than ChIFN-
a and is composed of 176 amino acids. It has a calculated mo-
lecular mass of 20,372 and features two potential N-linked
glycosylation sites. In contrast to IFN-a, there is a single gene
in the chicken that codes for IFN-b.(9) It maps to the short arm
of the chicken Z chromosome, like the IFN-a genes.(12) A poly-
clonal antiserum that neutralizes the antiviral activity of ChIFN-
a failed to neutralize ChIFN-b, indicating that (reminiscent of
the situation in mammals) the chicken has two serologically
distinct type I IFN.(9) rChIFN-b from E. coli or transfected mon-
key COS cells is active, although its specific antiviral activity
is at least 20-fold less than that of ChIFN-a.(9)
The existence of two serologically distinct families of type
I IFN in the chicken is of great interest from an evolutionary
point of view. Phylogenetic analyses indicated that the mam-
malian IFN-a and IFN-b genes originated by duplication of a
progenitor gene after the divergence of birds, most probably
about 250 million years ago.(8) The same type of phylogenetic
analysis further indicated that the ChIFN-a and ChIFN-b genes
originate from a separate duplication event that occurred inde-
pendently at a later time.(8) However, several experimental find-
ings argue against this view and suggest rather that the critical
gene duplication actually took place before the avian and mam-
malian lineages diverged.
First, ChIFN-a and ChIFN-b genes are strongly expressed
in response to viral infection of monocyte-derived macro-
phages(10) or embryo fibroblasts (Fig. 1A), whereas only the
IFN-a but not the IFN-b genes are expressed in spleen (Fig.
1B) and thymus(10) of chickens treated orally with the immune-
modifying imidazoquinoline S-28463.(14) This differential reg-
ulation of IFN-a and IFN-b genes in response to the two dif-
ferent inducing agents resembles that previously observed with
human cells.(15) Second, the promoter of the ChIFN-b gene con-
tains a cluster of putative binding sites for transcription factors
NF-kB and IFN regulatory factor (IRF) that is essential for virus
inducibility.(10) A similar set of regulatory elements is present
at the corresponding position in the promoters of mammalian
IFN-b but not IFN-a genes.(16) Like their mammalian counter-
parts, the ChIFN-a genes further lack binding sites for NF-
kB.(10) Third, as in most mammals, we find a large IFN-a gene
family and a single IFN-b gene in the chicken. It thus appears
most unlikely that two independent gene duplications in birds
and mammals could have resulted in genetic setups that re-
semble each other to this great extent.
IFN-a genes of other birds (Table 1) have been cloned by
employing homology screening approaches. Identity to ChIFN-
a at the amino acid level varies from 82% in turkey(17) to 50%
in the duck.(18) The cloned duck gene was recognized to be a
member of a family of approximately 10 related genes,(11) sug-
gesting that IFN-a gene clusters may exist in all birds. No IFN-
b gene of birds other than that of chickens have been described
to date. This raises the question whether IFN-b plays a role in
the innate immune response of birds. Infection experiments of
the type shown in Figure 1A clearly demonstrate that the
ChIFN-b gene is strongly expressed in virus-infected cells, sug-
gesting that its product may play a role in virus defense simi-
lar to that of mammalian IFN-b.
Little is known about type I IFN receptors and receptor-as-
sociated proteins in birds. A comparative genomic analysis of
genetic loci located next to the GART gene in humans and
chickens revealed two conserved genes, IFNAR-1 (accession
number AF082664) and IFNAR-2 (accession number
AF082665), that seem to code for the two subunits of the type
I IFN receptor.(19) Other studies further indicated that the Jak-
Stat signaling pathway, which mediates IFN signal transduc-
tion in mammals, is also operative in cells from birds.(20–23)
Taken together, these findings indicate that most elements of
the mammalian type I IFN system have been conserved in birds.
IFN-g. IFN-g represents the major macrophage-activating
factor (MAF), exhibits antiviral activity, and drives Th1 im-
mune responses (for reviews see refs. 24, 25). Before the first
ChIFN gene was cloned, it appeared that birds might possess
an archetype IFN species that combines the known properties
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TABLE 1. LIST OF CLONED AVIAN CYTOKINE CDNA
Cytokine Accession number References
Chicken
Interferons
IFN-a family members U07868, X92476, X92477, X92478 7, 9
IFN-b X92479 9
IFN-g U27465, X99774 28, 29
Interleukins
IL-1b Y15006 50
IL-2 AF000631 59
IL-6 AJ309540, AI982185 88
IL-15 AF139097, AF152927
IL-16 AJ399362
IL-18 AJ277865 105
Chemokines
CXC chemokines
cCAF (9E3/CEF4) M16199 112
K60 Y14971 113
JSC AF285876
CXCL DT40 AJ393586
CXCL pat AI981378
MDV vIL-8 AF065430 117
CC chemokines
MIP-1b Q90826 176
CCL AI980712
K203 Y18692 113
TARC AI980713
RANTES AI982103
TCA L34552 175
FPV-116 AAF44460
FPV-121 AAF44465
C chemokines
Lymphotactin (Ltn) AF006742 118
Others
cMGF M85034 89
TGF-b M31154, M31160 177, 178
CD40L AI982044
BAFF/BlyS AJ397416
Turkey
Interferons
IFN-a U28140 17
IFN-g AJ000725 34
Interleukin
IL-2 AJ007463 60
Duck
Interferon
IFN-a X84764 18
IFN-g AF087134, AF100929 32, 33
Interleukin
IL-18 AF336122
Pheasant
Interferon
IFN-g AJ001289 34
Quail
Interferon
IFN-g AJ001678 34
Guinea fowl
Interferon
IFN-g AJ001263 34
of mammalian IFN-a, IFN-b, and IFN-g in a single molecule.
This view was mainly based on results of experiments per-
formed with ConA-stimulated chicken spleen cells. Mammalian
spleen cells exclusively release IFN-g under these induction
conditions that is highly sensitive to heat and acid treatment.
Surprisingly, chicken spleen cell supernatants exhibited not
only MAF activity but also antiviral activity with the physio-
chemical properties of mammalian type I IFN, for example, re-
sistance to heat and acid treatment.(26) This concept was dis-
turbed by the observations that rChIFN-a is a potent antiviral
factor that lacks MAF activity(27) and that a monoclonal anti-
body (mAb) to rChIFN-a (designated 8A9) neutralized most of
the antiviral activity present in the supernatants of ConA-stim-
ulated chicken spleen cells without affecting the MAF activ-
ity.(28)
cDNA encoding the chicken homolog of mammalian IFN-
g (Table 1) were cloned independently by two laboratories
using different functional screening approaches.(28,29) Both
groups expressed cDNA libraries prepared from chicken T
cells in transfected monkey COS cells and screened the re-
sulting supernatants for antiviral and nitric oxide (NO)-in-
ducing activity(29) or for an activity that induced expression
of the guanylate-binding protein (GBP) gene in CEC-32
cells.(28) ChIFN-g mRNA has an open reading frame (ORF)
that codes for a polypeptide of 164 amino acids whose se-
quence shows ,34% identity to mammalian IFN-g. The N-
terminal 19 amino acids serve as a signal peptide. Secreted
ChIFN-g consists of 145 amino acids (calculated molecular
mass , 18,000). The IFN-g gene has been mapped to chicken
chromosome 1.(30) rChIFN-g expressed in either monkey
COS cells or E. coli is biologically active. Like mammalian
IFN-g, it is sensitive to heat and acid treatment.(29) It potently
induces the expression of genes known to be inducible by
IFN-g in mammals, including IRF-1, GBP, NO synthase
(NOS)-2, and genes for MHC class II antigens, suggesting
that most elements of this system are conserved as well.
ChIFN-a and ChIFN-g act synergistically,(31) demonstrating
another feature shared by the mammalian and avian IFN sys-
tems. A polyclonal antiserum against rChIFN-g neutralized
the MAF activity in supernatants of ConA-treated spleen cells
but had little effect on the antiviral activity,(28) confirming
the view that most of the antiviral activity in such supernatants
is probably due to the presence of IFN-a. Thus, unlike mam-
malian spleen cells, spleen cells from chickens seem to pro-
duce a mixture of type I and type II IFN in response to stim-
ulation by mitogen. By homology screening, IFN-g cDNA of
other birds have been cloned recently (Table 1). IFN-g from
turkey, pheasant, and quail show a high degree of identity to
ChIFN-g, whereas IFN-g from ducks is only 67% identi-
cal.(32–34) Nevertheless, duck IFN-g showed antiviral activity
on chicken fibroblasts, albeit , 16-fold less than on duck fi-
broblasts. Interestingly, recombinant duck IFN-g strongly
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FIG. 1. Differential induction of ChIFN-a and ChIFN-b genes in response to viruses and the imidazoquinoline S-28463. (A)
Cultures of primary chicken embryo cells were either left untreated (lane 1), infected with a mutant of influenza A virus lacking
the gene for nonstructural protein 1 (NS1) at a multiplicity of infection of 1 (lane 2), or infected with Newcastle disease virus at
a multiplicity of 10 (lane 3). RNA was prepared 24 h later, and samples were analyzed by Northern blotting for the presence of
transcripts derived from IFN-a and IFN-b genes. (B) Three-week-old chickens were treated orally with either 2.5 mg S-28463
per kg body weight (lane 2) or mock-treated with distilled water (lane 1). The animals were killed 75 min later, and the spleens
were removed and snap-frozen in liquid nitrogen before RNA was prepared. Samples were analyzed by Northern blotting for the
presence of transcripts derived from IFN-a and IFN-b genes. Reprobing of the membranes with chicken GAPDH cDNA dem-
onstrated that comparable amounts of RNA were loaded into the various lanes.
blocked the replication of duck hepatitis virus in primary duck
hepatocytes.(32)
Many poxviruses code for secreted soluble factors with IFN-
g binding activity that block the interaction between cytokine
and cellular receptor (for review, see ref. 35). The protein en-
coded by the B8R gene of vaccinia virus binds IFN-g of most
mammals. Interestingly, it can also bind to ChIFN-g, thereby
neutralizing its GBP-inducing and NO-inducing activity.(36)
These results indicate that in spite of the low conservation of
primary sequence, the tertiary structures of chicken and mam-
malian IFN-g must be quite similar.(157)
Interleukins
IL-1. Mammalian IL-1 was identified initially as a macro-
phage-derived factor with lymphocyte costimulating activ-
ity.(37) Subsequent work showed that IL-1 acts not only on T
lymphocytes and thymocytes but also on a wide variety of other
cells, thereby regulating the host response to infection and in-
jury. The pleiotropic activities of IL-1 include its T cell comi-
togenic property, induction of fever, activation of the hypo-
thalamic-pituitary axis and glucocorticoid secretion, triggering
of the acute-phase response, and activation of the vascular en-
dothelium. Many of the activities of IL-1 are mediated through
its ability to induce other cytokines, such as the proinflamma-
tory cytokines IL-6 and tumor necrosis-factor-a (TNF-a), and
several chemokines (for reviews, see refs. 38, 39). Three struc-
turally related members of the IL-1 cytokine family have been
described in mammals. IL-1a and IL-1b are biologically active
cytokines that are specifically inhibited by the third family
member, termed IL-1 receptor antagonist (IL-1Ra).
In the chicken, an IL-1-like biologic activity was first dem-
onstrated in supernatants of lipopolysaccharide (LPS)-stimu-
lated adherent spleen cells.(40) Chicken thymocytes were stim-
ulated with a suboptimal dose of mitogen that led to a weak
proliferative response, which was strongly enhanced on addi-
tion of preparations containing crude IL-1. Using this assay it
became clear that Staphylococcus aureus, LPS, phorbol esters,
and silica all induced IL-1 secretion in primary chicken mac-
rophages and in the macrophage cell lines HD-11 and MQ-
NCSU.(40–43) Induction of ChIL-1 secretion was shown to be
dependent on protein kinase C (PKC), calmodulin-dependent
protein kinase,(42) and calcium.(44) A number of additional bi-
ologic activities, including induction of fibrinogen and metal-
lothionein synthesis in hepatocytes,(45,46) induction of fever and
anorexia,(47) and increased weight gain and feed intake,(48) were
all attributed to an IL-1-like factor. IL-1-like bioactivity was
also found in supernatants of ConA-stimulated chicken sple-
nocytes. The protein exhibiting this activity was partially puri-
fied by immunoaffinity chromatography using a rabbit antihu-
man IL-1a/b antibody.(49) The enriched protein preparation
induced the release of corticosterone in vivo.
Isolation of a cDNA encoding ChIL-1b (Table 1) was
achieved by expression cloning using a cDNA library prepared
from LPS-stimulated HD-11 cells.(50) The bioassay employed
in this work relied on the fact that IL-1 strongly activated a
CXC chemokine gene (K60) in target cells. The primary trans-
lation product of ChIL-1b cDNA consists of 267 amino acids
and shows 25% similarity to human IL-1b (HuIL-1b). Like its
mammalian counterparts, ChIL-1b lacks a signal peptide and
seems to be synthesized as an inactive precursor molecule. In-
terestingly, the characteristic caspase-1 protease cleavage site
is not conserved in chicken pro-IL-1b. A fragment corre-
sponding to putative mature ChIL-1b that comprises amino
acids 106–267 was expressed in E. coli and shown to be bio-
logically active. It induced the synthesis of K60 mRNA in an
avian fibroblast cell line and it strongly upregulated corticos-
terone secretion in vivo.(50) cDNA for the chicken homolog of
IL-1a or IL-1Ra have not been identified to date.
In mammals, two distinct IL-1 receptors (IL-1R1 and IL-
1R2) have been described. Ligand binding to IL-1R1 leads to
pronounced cellular responses. In contrast, IL-1R2 acts as a de-
coy receptor that binds ligand without transducing an activat-
ing signal. ChIL-1R1 cDNA has been cloned.(51) It shows 60%
amino acid similarity to murine and human IL-1R1 (MuIL-1RI
and HuIL-1R1). Recently, Klasing and Peng(52) expressed the
entire extracellular region of ChIL-1R1 in the yeast Pichia pas-
toris, which resulted in the synthesis of an IL-1 binding pro-
tein that partially inhibited the biologic activity of natural prepa-
rations of ChIL-1. This recombinant protein was used to
generate a neutralizing antiserum. Both soluble receptor and an-
tireceptor antibodies will be valuable tools for future work
aimed at elucidating the in vivo function of ChIL-1.
IL-2 and IL-15. IL-2 and IL-15 are two structurally related
cytokines with overlapping biologic functions (for recent re-
views, see refs. 53–56). Following several unsuccessful at-
tempts to clone chicken IL-2 using either partial protein pu-
rification or cross-hybridization,(57,58) IL-2 cDNA (Table 1)
was identified by COS cell expression cloning using a bioas-
say.(59) The 747-bp ChIL-2 cDNA has a 429-bp ORF that codes
for a protein of 14.5 kDa with a predicted signal peptide of 22
amino acids. The 298-bp 39-UTR contains five repeats of the
RNA instability motif ATTTA. Interestingly, turkey IL-2 and
ChIL-2 share only 70% amino acid identity, although they
cross-react in functional assays.(60)
The overall amino acid identity to mammalian IL-2 and IL-
15 is only , 24%. ChIL-2 harbors four cysteine residues that
can potentially form two intrachain disulfide bonds, which is a
feature of mammalian IL-15 but not IL-2. For this reason, it
was initially thought that ChIL-2 might represent an ancestral
form of a cytokine that may combine features of mammalian
IL-2 and IL-15.(59) This view is probably incorrect, as evidenced
by recent results of genomic analyses of the ChIL-2 gene and
the identification of a ChIL-15 cDNA in an expressed sequence
tag (EST) database (see below). ChIL-2 and ChIL-15 both con-
tain structural features characteristic of four a-helix bundle cy-
tokines.
The ChIL-2 gene is located on chromosome 4 linked to an-
nexin 5 with synteny to mouse chromosome 3 and human chro-
mosome 4, respectively.(61) A 3.8-kb fragment of the ChIL-2
locus (accession No. AJ224516) contains four exons and three
introns with structures similar to mammalian IL-2 genes. The
promoter sequence contains a TATAAA box and several con-
served potential regulatory sequences, including NF-AT, AP-
1, and CD28 response elements. The NF-kB and octamer bind-
ing sites of mammalian IL-2 promoters are less well conserved.
Analyses of eight inbred chicken lines suggested that IL-2 is a
single copy gene without detectable polymorphism.(61)
IL-15 was identified in an EST database from chicken
liver(62) (Table 1). The 857-bp ChIL-15 cDNA encodes a 187-
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residue polypeptide that shows about 38% identity to HuIL-15.
Identity of this protein to ChIL-2 is very low apart from the
four conserved cysteines. It has been demonstrated in mammals
that several upstream AUG of the 59-UTR and an unusual, long
signal peptide impede effective translation of IL-15 mRNA.(63)
The ChIL-15 mRNA has only three upstream AUG as opposed
to 12 in the human counterpart. However, the signal peptide of
ChIL-15 is longer, consisting of 63 amino acids.
Mammalian IL-2 and IL-15 receptors are composed of three
subunits. Both cytokines have their own specific a chains but
share the b chain. The common g chain is used as signal trans-
ducing molecule by a variety of other cytokine receptors, in-
cluding those for IL-4, IL-7, IL-9, and IL-21. Mutational anal-
ysis of ChIL-2 showed that an N-terminal asparagine and the
entire C-terminus are critical for IL-2 function, indicating that
these regions of the ligand might be essential for receptor trig-
gering.(64) An mAb designated INN-CH-16, reacts with a
48–50-kDa antigen expressed on activated T lymphocytes and
inhibits the proliferation of ConA blasts in response to super-
natants of stimulated T cells. These features led to the hypoth-
esis that INN-CH-16 may recognize the ChIL-2R.(65,66) A can-
didate cDNA clone for the ChIL-2R a chain recently was
deposited in the database (accession number AF143806). It is
unclear at present if this protein is recognized by INN-CH-16.
The predicted ChIL-2R a chain shows about 30% amino acid
identity to the mammalian counterparts and contains a typical
Sushi domain, but, interestingly, it lacks the entire cytoplasmic
domain. A partial sequence of the IL-15R a chain has been de-
posited in the database (accession number AI980376). Because
of the shortness of the cloned cDNA fragment, its identifica-
tion as IL-15R a chain must remain preliminary.
Several chicken EST clones with homology to the common
g chain have been isolated.(62) Although the different clones do
not contain the complete ORF, they cover a highly conserved
extracellular domain ( , 40% amino acid identity to mammalian
counterparts), including a 19-residue signal peptide, a fi-
bronectin-like domain, and a 20-amino acid transmembrane re-
gion. The presence of four conserved cysteines and the canon-
ical WSXWS motif clearly identify this protein as a member
of the cytokine I superfamily of receptors.(67) Taken together,
these preliminary analyses in the chicken allow the conclusion
that the IL-2/IL-15 receptors most likely have a mammalian-
type structure.
Before rChIL-2 was available, crude supernatants of ConA-
stimulated splenocytes or partially purified IL-2 were used to
study various aspects of the biology of this cytokine. These ex-
periments have been summarized elsewhere.(68) They still need
to be validated using rIL-2 preparations and neutralizing mAb.
In spite of these technical limitations, a number of different ex-
periments clearly indicated that ChIL-2 induces proliferation of
T cells and natural killer (NK) cells and enhances their cytolytic
activity.(69) IL-2 bioactivity traditionally has been measured in
proliferation assays using splenocytes that are activated with
ConA for 48 h.(59) These T lymphocyte blasts respond very well
to rIL-2. However, this assay is not very sensitive, and minute
amounts of secreted IL-2 cannot be measured accurately be-
cause of the high background levels of preactivated cells. More-
over, it is likely that the ConA blasts will also respond to a va-
riety of other soluble factors, which may have led to inaccurate
conclusions. Unfortunately, alternative assay procedures have
not been described to date, and the various cell lines previously
classified as “IL-2 sensitive” were tested without success for
proliferative responses to rIL-2. As the ChIL-15 cDNA se-
quence has been deposited in the database only recently, rChIL-
15 is only beginning to be produced in several laboratories, and
no information on its biologic activity is available. As for IL-
2, it will be essential to develop a reliable and sensitive bioas-
say for IL-15 in order to elucidate its function in the chicken
immune system.
IL-6. IL-6 in mammals is a multifunctional cytokine pro-
duced by T and B lymphocytes, endothelial cells, mono-
cytes/macrophages, and fibroblasts.(70) The huge diversity of
biologic activities of IL-6 is exemplified by a long list of al-
ternative names (B cell differentiation factor [BCDF], B cell
stimulation factor [BSF-2], hepatocyte-stimulating factor
[HSF], IFN-b2).(71) IL-6 is a potent B cell hybridoma growth
factor(72) and regulator of immunoglobulin synthesis.(73) It was
long known for its role in the initial activation of T lympho-
cytes.(74) It has been shown to promote the development of Th2
immune responses by inducing IL-4 synthesis(75) and to inhibit
Th1 differentiation by upregulating the suppressor of cytokine
signaling 1 (SOCS-1).(76) The important role of IL-6 as an im-
munoregulator is further underscored by its ability to switch
monocyte differentiation from dendritic cells to macro-
phages.(77) It also enhances the proliferation of multipotential
hematopoietic progenitors. One of the major biologic effects of
IL-6 is the induction of an acute-phase response. IL-6 released
in response to infections, injuries, malignant tumors, and im-
munologic disorders profoundly modulates the protein secre-
tion pattern of the liver, the fever response, and secretion of
corticosteroids.(78)
Early work in chickens focused on the demonstration of IL-
6-like biologic activities in various assay systems. Amrani et
al.(79) showed that LPS-stimulated macrophages secreted an
HSF that induced fibronectin production by cultured hepato-
cytes. HSF was also secreted by LPS-treated fibroblasts and
could be neutralized by an antiserum to rHuIL-6. Furthermore,
rHuIL-6 was biologically active on chicken hepatocytes,(80)
strongly indicating the existence of a highly conserved IL-6 sys-
tem in birds. Further evidence in support of this view came from
studies that demonstrated an IL-6-like activity in chicken
serum(81) and chicken ascites fluids(82) that strongly induced
proliferation of certain murine hybridoma cell lines. The ascites
fluid activity could be neutralized by an antiserum to HuIL-
6.(82) Antibodies raised against mammalian IL-6 were also re-
ported to detect ChIL-6 in thymic tissue sections.(83) Several
bioassays for detection of ChIL-6 have been established that
are based on the production of fibronectin by a chicken hepa-
tocyte cell line(84) or the induction of proliferative responses in
murine hybridoma cell lines, including B9(82) and 7TD1.(85)
Employing these assay systems, IL-6-like activities were dem-
onstrated in serum of Eimeria-infected birds,(85) in turkey poults
suffering from poult enteritis and mortality syndrome,(86) and
in supernatants of LPS-stimulated chicken heterophil cul-
tures.(87)
Using suppression subtractive hybridization technology,
Schneider et al.(88) identified an mRNA in spleens of imidazo-
quinoline-treated chickens that showed ,35% identity at the
amino acid level to mammalian IL-6 (Table 1). In addition, a
cDNA fragment of the same gene was identified in an EST data-
base generated from ConA-treated chicken T lymphocytes
(Table 1). The 1.5-kb ChIL-6 mRNA harbors eight ATTTA
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RNA instability motifs in the 39-UTR that are typically found
in cytokine mRNA. Its translation product features an unusu-
ally long signal peptide of 47 amino acids. ChIL-6 shares a
common motif consisting of four cysteine residues with mam-
malian IL-6, granulocyte colony-stimulating factor (G-CSF),
and chicken myelomonocytic growth factor (cMGF). The ma-
ture secreted form of ChIL-6 appears to consist of 194 amino
acids, with a calculated molecular mass of , 22,000. However,
the molecular weight of natural ChIL-6 is approximately 35
kDa,(82) indicating extensive posttranslational modification.
rChIL-6 produced in E. coli induces proliferation of murine
7TD1 cells at similar concentrations and to a similar extent as
rHuIL-6.(88) Thus, IL-6 seems to be exceptional among ChIL
and ChIFN, as it exhibits biologic activity across species bound-
aries. The in vivo biologic activity of rChIL-6 was further dem-
onstrated by showing that it can induce serum corticosterone
accumulation after intravenous application to chickens.
cMGF was found to be distantly related to mammalian IL-
6, G-CSF, and ChIL-6. In their original work Leutz et al.(89) ar-
rived at the conclusion that cMGF is most likely not the avian
homolog of mammalian IL-6. Nevertheless, some authors who
used cMGF as a marker to monitor cytokine responses in ex-
perimental infections of chickens continue to call this cytokine
IL-6.(90,91) As bona fide ChIL-6 has now been cloned, this con-
fusing nomenclature should no longer be used.(88)
IL-8. Chemokines that may represent the chicken homolog
of IL-8 are discussed under the heading of Chemokines.
IL-16. IL-16 is an immunomodulatory cytokine first de-
scribed in 1982 as a T cell chemoattractant factor.(92,93) IL-16
is synthesized by a variety of immune and nonimmune cells as
a biologically inactive precursor molecule of approximately
70–80 kDa. Like IL-1b and IL-18, IL-16 lacks a signal pep-
tide. In mammals, pro-IL-16 is processed into the mature form
by caspase-3. Secreted IL-16 aggregates to form biologically
active homotetramers, which then bind to CD4. New data in-
dicate that CD4 is not the only receptor for IL-16.(94) IL-16 has
pleiotropic functions. It exhibits chemoattractant activity to-
ward T cells, monocytes, and eosinophils, it activates prolifer-
ation of T cells, and it induces in target cells the expression of
HLA-DR, IL-2Ra chain, and various cytokines genes, includ-
ing IL-1b, IL-6, IL-15, and TNF-a (for reviews, see refs. 95,
96).
Analysis of BLAST search results from a chicken bursal EST
database identified a cDNA clone that contains sequence in-
formation for ChIL-16 (Table 1). It contains information on the
C-terminal moiety of ChIL-16, including the complete sequence
of the putative mature form of this cytokine. ChIL-16 shows a
surprisingly high similarity to mammalian IL-16. It shows 64%
identity to HuIL-16 (Fig. 2). If conservative amino acids are
taken into account, similarity is , 75%. No functional data are
available at present.
IL-18. IL-18 was originally purified from livers of mice
treated with Propionibacterium acnes, followed by LPS stim-
ulation.(97) It enhances the cytotoxic activity of CD8 T cells(98)
and NK cells(99) and promotes Th1 or Th2 differentiation de-
pending on its cytokine milieu.(100–102) A characteristic prop-
erty of IL-18 is its ability to induce in target cells the secretion
of IFN-g. For this reason, IL-18 was originally designated IFN-
g-inducing factor (IGIF).(97) IL-18 synthesis is regulated at the
protein level. It is synthesized as a precursor molecule that is
activated by caspase-1 cleavage after a conserved aspartate
residue.(103,104)
A cDNA for ChIL-18 was identified by screening the
BLAST search results of an EST database generated from a
chicken B cell line (Table 1). ChIL-18 mRNA contains an ORF
of 597 nucleotides (nt) that codes for a protein of 198 amino
acid residues that shows , 30% identity to IL-18 from mam-
mals.(105) Sequence alignments identified a conserved aspartate
residue that is probably recognized by caspase-1. After prote-
olytic cleavage, the putative mature ChIL-18 comprises 169
amino acids. This molecule was produced in E. coli and sub-
sequently was shown to be biologically active in an IFN-g in-
duction assay using chicken spleen cells(105) (Table 2).
A recent database entry (Table 1) provides sequence infor-
mation on IL-18 of ducks. The putative mature forms of duck
IL-18 and ChIL-18 show a high degree of identity (, 88%) (Fig.
3). No information is available to date on the biologic activity
of duck IL-18.
In mammals, induction of IFN-g by IL-18 is dependent on
IL-12. The synergism between these cytokines is the result of
IL-12-mediated upregulation of the IL-18 receptor.(106) IL-18
and IL-12 further activate complementary sets of transcription
factors that regulate the activity of the IFN-g promoter.(107)
ChIL-18 showed good activity in the splenocyte assay in the
absence of exogenous IL-12,(105) indicating that avian IL-18
differs from its mammalian counterpart(106) in that it requires
no costimulatory signal. However, we recently found interest-
ing differences between splenocytes from B19 inbred chickens
and splenocytes from an outbred chicken line. In cells from the
latter animals, rChIL-18 was inactive unless a costimulatory
signal was provided by T cell receptor (TCR) cross-linking us-
ing an anti-a/b TCR mAb (TCR-2) (unpublished observations).
The genomes of several poxviruses code for IL-18-binding
proteins that are believed to play a role in the viral evasion strat-
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FIG. 2. High similarity of chicken and mammalian IL-16. Alignment of the two amino acid sequences was done using the Jo-
tun-Hein method. The N-terminal parts of the propeptides located upstream of the putative caspase-3 cleavage sites are not de-
picted. Identical amino acids are represented by periods. The GLGF motif shaded in gray is needed for tetramerization of IL-16
monomers. The arrow points to a conserved aspartate residue that marks the caspase-3 cleavage sites in mammalian IL-16. Over-
all identity between putative mature ChIL-16 and HuIL-16 is 64%.
egy.(108,109) The product of the fowlpox virus gene FPV-073
has structural features that make it a good candidate IL-18-bind-
ing protein.(110) It still remains to be demonstrated that this vi-
ral protein in fact exhibits such activity.
Chemokines
Chemokines are a group of small (, 8–14 kDa), structurally
related proteins that regulate trafficking of various types of
leukocytes through interactions with seven-transmembrane, G
protein-coupled receptors (for a recent review, see ref. 111).
About 40 chemokines have been identified to date in humans.
They are divided into subfamilies on the basis of the arrange-
ment of the conserved N-terminal cysteine residues, CXC, CC,
C, and CX3C. Several genes of the chicken and of avian viruses
encoding CXC, CC, and C chemokines have been identified re-
cently (Fig. 4).
CXC chemokines. The best known chicken CXC chemokine
is a protein designated cCAF (Table 1 and Fig. 4). It is encoded
by the 9E3/CEF4 gene and exhibits both chemotactic and an-
giogenic factor activity (for a recent review, see ref. 112). cCAF
is secreted as a , 9-kDa molecule by a variety of cell types in
response to various forms of stress. It is then cleaved near the
N-terminus by plasmin to produce a smaller form ( , 7 kDa)
that binds to the extracellular matrix. On the chorioallantoic
membrane, cCAF is chemotactic for monocyte/macrophages
and lymphocytes at low concentrations. At higher concentra-
tions, cCAF no longer shows chemotactic activity but rather
stimulates sprouting and growth of blood vessels.
Very little is known about the other four chicken CXC
chemokines of which cDNA recently have been cloned and se-
quenced (Table 1 and Fig. 4). They all show a similar low de-
gree of identity (,50% at amino acid level) to mammalian CXC
chemokines. Most information on these chicken proteins re-
sulted from random sequencing of EST clones derived from
stimulated chicken immune cells. The exception is the
chemokine K60, which was identified by differential gene ex-
pression analysis of HD-11 cells.(113) K60 mRNA is absent in
nonstimulated HD-11 cells but accumulates rapidly in response
to LPS, IL-1b, and IFN-g. In fibroblasts, it is induced by IL-
1b but not IFN-g. It is of interest to note that cCAF and K60
both feature a conserved ELR motif located immediately up-
stream of the first cysteine residue, whereas the other known
chicken CXC chemokines do not. The ERL motif is found in
all mammalian CXC chemokines that target neutrophils.(114)
Cell migration studies with purified recombinant proteins are
required to understand the biologic activities of these molecules
in more detail. We would like to stress that information on pri-
mary cDNA structure alone is an insufficient basis to decide
which of the various chicken molecules known to date repre-
sents the bona fide homolog of mammalian CXC chemokines.
Two recent reports indicate that the primary structures of
CXC chemokine receptors are conserved to a higher degree be-
tween birds and mammals than their ligands. A chicken gene
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FIG. 3. High similarity of ChIL-18 and duck IL-18 precursors. Alignment of the amino acid sequences was done using the Jo-
tun-Hein method. The putative caspase-1 cleavage site is marked by an arrow. Identical amino acids are represented by periods;
alignment gaps are indicated by dashes. Overall identity is 81.8%. The putative mature forms of the two proteins are about 88%
identical.
TABLE 2. BIOASSAYS VALIDATED FOR BOTH RECOMBINANT AND NATURAL CHICKEN CYTOKINES
Cytokine Bioassay Reference Neutralizing antibodies/reagents Reference
IL-1 Thymocyte comitogenesis assay 41, 180 Soluble IL-1 receptor (sIL-1RI) and 52
CXC chemokine (K60) induction assay 50 anti-IL1RI both neutralize natural
IL-1 activity
IL-2 Splenocyte proliferation assay 69, 180 Anti-ChIL-2 mAb 10E7 or 4F12 179
IL-6 IL-6-dependent proliferation of murine 82, 88
hybridoma cell lines (B9 or 7TD1)
IL-18 IL-18-induced IFN-g secretion by chicken 105
spleen cells (see also IFN-g assay)
IFN-a Antiviral assay 7, 9, 180 Anti-IFN-a mAb 8A9 171
IFN-b Antiviral assay 7, 9, 180
IFN-g Induction of NO synthesis in HD-11 cells 29, 180 Anti-ChIFN-g mAb 1E12 181
cMGF Proliferation of E26-transformed myeloblasts 120
cCAF Chorioallantoic membrane assay 112
encoding a seven-transmembrane domain protein showing all
structural characteristics of a chemokine receptor (accession
number AF294794) has 67% and 65% sequence identity to hu-
man CXCR1 and CXCR2, respectively.(115) Furthermore, a
chicken cDNA encoding a 359-residue polypeptide with 82%
identity to human CXCR4 (accession number AF227961) was
able to confer responsiveness to the human CXC chemokine
SDF-1 in transfected CHO cells, demonstrating that it is func-
tional.(116)
Marek’s disease virus (MDV) codes for a CXC chemokine,
designated vIL-8 (Table 1 and Fig. 4). The vIL-8 gene is ex-
pressed late in the viral multiplication cycle. It consists of three
exons that map to the repeats flanking the unique long region
of the viral genome.(117) Baculovirus-expressed vIL-8 attracts
peripheral blood mononuclear cells (PBMC) but not het-
erophils. As mammalian IL-8 has a different target cell speci-
ficity, the name of this viral chemokine is misleading. A re-
combinant MDV mutant strain with a deletion of the vIL-8 gene
showed a decreased level of lytic infection, but it retained its
oncogenicity, albeit at a greatly reduced level. It was hypothe-
sized that vIL-8 might be involved in leukocyte target recruit-
ment or else might play a role in viral immunoevasion.(117) It
is of interest to note that vIL-8 shows an unexpectedly high de-
gree of similarity to a chicken CXC chemokine (Fig. 4) (pro-
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FIG. 4. Chemokines of chicken, Marek’s disease virus, and fowlpox virus. Amino acid alignments were done using the Clustal
method. The conserved cysteine residues are shaded, and the putative signal peptides are underlined. Alignment gaps are indi-
cated by dashes. Sequences are identified by their common names shown in Table 1. The asterisk indicates that the listed pro-
tein sequence differs from that in the database. We corrected a sequencing error in the C-terminal moiety of the cDNA. Infor-
mation on the structure of the extreme N-terminal regions of CXCL DT40, TARC, and RANTES is not available.
visionally designated CXCL DT40), suggesting that MDV hi-
jacked this gene from its host.
CC chemokines.Five different chicken CC chemokine cDNA
have been cloned and sequenced to date (Table 1 and Fig. 4).
They show ,50% identity at the amino acid level to mam-
malian CC chemokines. Interestingly, the identity of these
chemokines with each other also is not much greater, indicat-
ing that they may serve distinct functions. Most information on
chicken CC chemokines resulted from random sequencing of
EST clones derived from stimulated chicken immune cells.
K203 was identified by differential gene expression analysis of
HD-11 cells.(113) Expression of the K203 gene is upregulated
strongly in various cell lines in response to LPS, IL-1b, and
IFN-g,(113) as well as in lymphoid organs of chickens treated
with the imidazoquinoline S-28463 (unpublished observations).
As mentioned, sequence information alone is not sufficient for
accurate predictions about the biologic activities of these mol-
ecules. Thus, although Figure 4 lists molecules designated MIP-
1b and RANTES, their true identity needs to be verified by ap-
propriate cell migration assays.
The products of four genes in the fowlpox virus genome have
structural features reminiscent of CC chemokines.(110) Our se-
quence alignments (Fig. 4) indicated that FPV-116 and FPV-
121 (Table 1 and Fig. 1) might represent virus-encoded CC
chemokines. No information is available to date on whether
these molecules are able to attract immune cells or interfere
with the activity of cellular CC chemokines via receptor com-
petition.
C chemokines. A cDNA for a chicken C chemokine (Table
1 and Fig. 4) related to mammalian lymphotactin has been de-
scribed. This molecule shows the typical cysteine pattern, but
the long C-terminal tail found in mammalian lymphotactin is
replaced by a short extension that is rich in arginine
residues.(118) Amino acid sequence identity to human and
mouse lymphotactins is only 28% and 33%, respectively. In-
terestingly, recombinant chicken lymphotactin produced in
transfected COS cells preferentially induced migration of spleen
B cells (rather than T cells) in classic transwell plate assays.
The chicken lymphotactin gene is constitutively expressed in
spleens of chickens.(118)
Other cytokines
Myelomonocytic growth factor. cMGF was the first chicken
cytokine to be fully characterized on the molecular level. Ini-
tially, cMGF was purified to homogeneity from LPS-activated
HD-11 cell culture supernatants. Based on protein sequence
data, cMGF was cloned from a myeloblast cDNA library. It is
a secretory protein consisting of 201 amino acids with a cal-
culated molecular mass of , 20,000.(89) Posttranslational gly-
cosylation and sulfation result in a variety of cMGF iso-
forms.(119) However, glycosylation is not required for its
biologic activity, as protein expressed in bacteria induced
myeloblast proliferation at low concentrations.(89) The cMGF
cDNA (Table 1) shows a weak structural relationship to mam-
malian IL-6 and G-CSF over its entire length. In particular, four
conserved cysteines are present that are also found in ChIL-6.
cMGF induces the growth of macrophage colonies and, to a
lesser extent, of granulocyte colonies from bone mar-
row.(120–122) It further enhances osteoclast differentiation(123)
and stimulates the growth of v-myb or v-myc transformed
chicken myeloid cells.(124,125) Binding of cMGF to myeloid pro-
genitor cells causes rapid Stat5 phosphorylation, followed by
cell proliferation and differentiation.(126) Infection of birds with
a recombinant fowlpox virus expressing cMGF significantly in-
creased the number of circulating monocytes.(127)
cMGF is secreted by lectin-activated lymphocytes and LPS-
stimulated myeloid cells. In addition, infection of myeloid cells
with retroviruses carrying kinase-type oncogenes causes cMGF
production. Gene expression is stimulated by NF-M, a myeloid-
specific transcription factor that binds to the cMGF pro-
moter.(128,129) More recently, cMGF gene expression was
shown in response to infectious bursal disease viral infection(90)
and MDV infection.(91)
Transforming growth factor-b (TGF-b). Members of the
TGF-b family are important regulators of cell growth and dif-
ferentiation (for a review, see ref. 130). In chickens, four dis-
tinct isoforms, TGF-b1 through 4, have been described that
share several structural features and show up to 82% identity
at the amino acid level.(131) Most studies in the chicken have
focused on the role of TGF-b in embryonic develop-
ment(131–135) and hematopoiesis.(136) TGF-b is known to play
an important role in immunologic tolerance in mammals. Lit-
tle is known about the putative immunoregulatory properties of
ChTGF-b. Interestingly, rHuTGF-b1 strongly inhibits prolifer-
ation of chicken T and B cells in vitro and was shown to sup-
port the development of suppressor T cells.(137) Furthermore,
HuTGF-b1 was found to enhance the expression of an inte-
grinlike antigen on intestinal T cells(138) and to regulate T cell
differentiation in the chicken thymus.(134) Increased TGF-b4
mRNA expression was demonstrated after coccidial infection
in two recent studies.(131,139)
TNF family members. TNF-a is a potent inflammatory cy-
tokine with pleiotropic functions.(140) Various biologic activi-
ties, including NO release, induction of MHC class II antigens
by macrophages, and effects on granulosa cell proliferation,
have been reported for unpurified or partially purified super-
natants of stimulated primary macrophages or macrophage cell
lines believed to contain the chicken homolog of TNF-
a.(141–144) Although some database entries claim that certain se-
quences represent fragments of the ChTNF-a gene, to our
knowledge, nucleic acids encoding this chicken cytokine have
not been identified to date. The molecular identification of
ChTNF-a and related genes will be essential to further charac-
terize its functions, especially as, in mammals, these cytokines
play key roles in the development of lymphoid organs.(145)
Two EST clones have been described (Table 1) that seem to
contain sequence information for the chicken homolog of CD40
ligand and the TNF family member BAFF/BlyS, respectively.
POTENTIAL USE OF AVIAN CYTOKINES
Important intrinsic features of commercial rearing of birds
include a very short life span and a low value of individual an-
imals, which greatly limit any therapeutic strategies aimed at
treating diseased flocks. The goal, therefore, is to have pro-
phylactic approaches in place that help to enhance pathogen re-
sistance of the animals. In the near future, the latter strategy
might greatly profit from the availability of recombinant cyto-
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kines. First attempts to demonstrate the feasibility of these novel
concepts are discussed.
Cytokines as vaccine adjuvants
Because cytokines are proteins that control the type and the
extent of immune responses after infection or vaccination, they
have the potential to serve as vaccine adjuvants. A recent study
in the mouse system showed that IFN-a/b is a powerful adju-
vant when coinjected with a soluble antigen.(146) Using sheep
red blood cells (RBC) as model antigens, Lowenthal et al.(147)
showed that the immune response in chickens was enhanced
when the vaccine contained rChIFN-g. Higher levels of spe-
cific antibodies were achieved in the presence of cytokine, and
lower antigen doses were effective. Similarly, significant im-
munoadjuvant activity of rIFN-g, rIFN-a/b, and rIL-1b was
observed in 3-week-old chickens immunized with tetanus tox-
oid as a bacterial model antigen.(148) Unlike oil-based adjuvants,
the specific enhancement of B cell responses mediated by cy-
tokines was associated with no or only minimal adverse reac-
tions. Interestingly, no significant adjuvant effect was recorded
when cytokines were applied in combination with inactivated
infectious bursal disease viral antigen or when 1-day-old chick-
ens were used.(148) An adjuvant effect on the antibody response
was also seen when soluble protein antigens were injected i.m.
together with IFN-g and a synthetic lipopeptide but not with
cytokine alone.(149) Antibody and T cell proliferative responses
to immunization with MDV glycoprotein B were strongly en-
hanced when latex microspheres coated with rIL-2 were coin-
jected with antigen into 3-week-old chickens.(150)
Few studies have assessed the immunomodulatory activity
of plasmid-expressed cytokines. Coinjection of DNA constructs
encoding chicken cytokines boosted the immune response to
tetanus toxoid.(148) However, this enhancing effect was mostly
if not exclusively due to the intrinsic adjuvant effect of plas-
mid DNA. Interestingly, the tetanus toxoid-specific primary an-
tibody response was selectively suppressed by plasmid-encoded
IFN-g, suggesting that this cytokine may actually inhibit anti-
body production under certain conditions. A similar inhibitory
effect of plasmid-expressed IFN-g was observed in turkeys vac-
cinated with DNA constructs expressing a Chlamydophila
psittaci antigen.(151) In contrast, coadministration of an Eime-
ria acervulina antigen with plasmids encoding either IFN-g or
IL-2 was reported to induce a more robust immunity than ad-
ministration of protozoal antigen alone.(152) It should be noted,
however, that in this study, no control immunizations were per-
formed with equal amounts of empty plasmid vector. Plasmid-
encoded IL-2-enhanced antibody responses to MDV glycopro-
tein B in 3-week-old chickens had no effect on T cell
proliferation.(150)
The vaccine efficacy of a recombinant fowlpox virus coex-
pressing a Newcastle disease virus (NDV) antigen and IFN-g
was evaluated in turkeys.(153) The antibody response after in
ovo vaccination developed earlier, and a larger proportion of
birds was protected from challenge with NDV when the IFN-
g gene was present in the vector. Interestingly, chickens im-
munized with a recombinant fowlpox virus coexpressing
ChIFN-a showed no enhanced immunity.(154) The decreased
vaccine potency of this cytokine-producing fowlpox virus vec-
tor was probably due to its attenuated phenotype in the chicken.
Infection of chickens with a recombinant fowlpox virus ex-
pressing cMGF was shown to cause a marked and sustained in-
crease in the number of circulating blood monocytes as well as
an increase in their state of activation.(127) Whether such ani-
mals would show enhanced vaccine responses is unknown.
Use of cytokines to enhance innate immunity
The IFN-a/b system of mammals contributes to innate im-
munity toward a wide range of viral pathogens, suggesting that
it may serve a similar function in birds. Marcus et al.(155) found
that oral administration of IFN-a ameliorated Newcastle dis-
ease in treated chickens. Some but not all chickens that received
high amounts of IFN-a via the drinking water resisted virus-
induced weight loss and showed strongly reduced pathology of
the tracheal tissue. Treatment of chickens with high doses of
rIFN-a in the drinking water also decreased the number of
virus-infected splenocytes after infection of the birds with
MDV.(156) Interestingly, the NK cell activity of splenocytes
from IFN-treated chickens was decreased rather than increased,
indicating that oral application of type I IFN may induce com-
plex changes in the immune response in chickens.
A series of intriguing experiments suggest that IFN-g has
potent growth-promoting properties in chickens that may result
from cytokine-induced enhancement of the innate immunity.
Injection of IFN-g into chicks or infection of chicks with re-
combinant avian adenovirus expressing IFN-g resulted in en-
hanced weight gain of the birds.(157,158) Furthermore, IFN-g-
treated animals showed better endurance to challenge with a
parasite.(159,160) It is of great interest to determine the mecha-
nism of this unexpected beneficial effect of IFN-g, which may
have an important impact on the broiler industry.
Cytokine profiling to assess the immune response and
the immune status of birds
Investigation of the cellular immune response in chickens
during infectious diseases had been hindered for a long time by
the lack of appropriate assay systems. From studies in mam-
mals, it is well known that analysis of cytokine expression dur-
ing the course of an infection can provide important informa-
tion on the host immune status and on mechanisms involved in
resistance or susceptibility to diseases. The various cloned
cDNA for avian cytokines permitted establishment of methods
for quantification of the corresponding mRNA as well as for
their translation products. Assaying for translation products
rather than for gene transcripts is of particular importance for
cytokines that are regulated at the posttranscriptional level, for
example, IL-1, IL-15, and IL-18.
Several techniques have been applied to study cytokine ex-
pression during coccidial parasite infection. Using standard RT-
PCR analysis, significantly increased IFN-g mRNA levels were
observed in the gut of infected birds.(161) These results were
confirmed independently by quantitative RT-PCR.(162) More
detailed studies revealed a complex picture of cytokine,(162,163)
chemokine,(162) and TGF synthesis(131) during Eimeria infec-
tion, which mirrors the induction of a highly inflammatory im-
mune response. IFN-g gene expression in response to coccidial
parasite infection could also be demonstrated at the protein
level(164) (for a review, see ref. 165). Lynagh et al.(85) measured
IL-6-like bioactivity in the sera of Eimeria-infected chickens.
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They observed a significant induction of this cytokine during
the first 2 weeks after infection.
In MDV infection models, cytokine expression profiles were
established by semiquantitative RT-PCR. A strong induction of
IFN-g mRNA was observed in spleens of infected birds as early
as 3 days after infection and up to day 15 postinfection, sug-
gesting a major role for IFN-g in the pathogenesis of Marek’s
disease.(91) Using microarray technology to investigate differ-
ential gene expression in MDV-infected chicken embryo fi-
broblasts, Morgan et al.(166) observed the induction of several
cytokines and cytokine-regulated immune response genes.
Cytokine expression in response to infection of chicken fi-
broblast cultures with different Salmonella serotypes was mon-
itored by quantitative RT-PCR and biologic assays. Again, a
complex expression profile emerged, indicating that pathogenic
serotypes may limit the inflammatory response and thereby
cause clinical disease.(167)
A recent report(168) suggests that transient immune suppres-
sion, which might be caused by such infectious agents as in-
fectious bursal disease virus or MDV, can be measured accu-
rately by assessing the animal’s ability to respond to inactivated
NDV with enhanced IFN-a and IFN-g gene expression.
Cytokines as tools for basic research in avian
immunology and virology
As cDNA for duck IFN-a(18) and IFN-g(32) have been cloned,
the duck model of hepatitis B virus (HBV) infection can now
be used to address open questions about the therapeutic use of
IFN in humans. Experiments with primary hepatocyte cultures
showed that both types of IFN effectively inhibit HBV repli-
cation.(18,32,169) Treatment of ducks with IFN-a had some in-
hibitory effect on HBV replication in the liver.(21) Furthermore,
when an IFN-a-expressing HBV vector was used to direct ex-
pression of this cytokine in liver cells of intact birds, an in-
hibitory effect on wild-type HBV replication was observed.(170)
A different experimental setup was used to show that IFN-
a can inhibit tumor formation induced by a transforming retro-
virus.(171) Intravenous injection of mAb 8A9, which neutralizes
IFN-a (Table 2), resulted in enhanced tumor development af-
ter Rous sarcoma virus infection of strain CB chickens that are
usually highly resistant to tumor formation. Furthermore, re-
peated intravenous injections of recombinant IFN-a into tumor-
susceptible chickens of strain CC conferred a significant degree
of resistance to Rous sarcoma virus-induced tumor formation.
Advanced knowledge of the avian cytokine system initiated
studies aimed at answering questions about immune evasion
strategies of viruses, with economic impact on the poultry in-
dustry. As discussed, the genomes of fowlpox virus and MDV
seem to code for chemokines as well as cytokine-binding pro-
teins (Fig. 4). The CXC chemokine encoded by MDV has in-
teresting chemoattractant properties and appears to function as
a virulence factor.(117) These initial data suggest that it may be
possible to alter the virulence of MDV vaccine strains by sim-
ple genetic manipulation of the viral CXC chemokine gene or
by replacing it with genes encoding wild-type or mutant forms
of its cellular counterpart.
Using the available novel tools, the roles of cytokines in the
autoimmune disease of a strain of obese chickens was analyzed.
These birds spontaneously develop a Hashimoto thyroiditis-like
disease. Thyroid glands of obese birds were found to contain
elevated levels of IL-2 and IL-15 mRNA in the initiation phase
of the disease in comparison to glands of CB control birds.(172)
In a second study, increasing levels of IFN-gmRNA were found
while the disease progressed. The functional relevance of IFN-
g in this autoimmune disorder was demonstrated by in vivo neu-
tralization studies with specific polyclonal antiserum. Anti-
serum treatment reduced the severity of the disease to nearly
50%.(173)
DISCUSSION
From the work on avian cytokines discussed in this paper, it
becomes increasingly clear that a highly developed cytokine
network is present not only in mammals but also in nonmam-
malian species. This is most clearly illustrated by the presence
of major components of the Th1 cytokine system in the chicken.
Studies on the phylogeny of cytokines can now be extended ap-
proximately 350 million years back to the time when the avian
and the mammalian lineage diverged. However, significant gaps
in our knowledge on chicken cytokines still exist. In this con-
text, it is of interest to note that no avian homolog of typical
Th2 cytokines (IL-4, IL-5, IL-10, and IL-13) has been molec-
ularly identified to date (Table 1). This suggests either that birds
lack these cytokines altogether or that cloning of chicken cy-
tokine cDNA was done with mRNA from cells that mainly ex-
pressed Th1 cytokine genes. Evidence in favor of the latter pos-
sibility is that chickens possess an IL-10R gene (accession
number AF082666) that shows 42% identity at the amino acid
level to HuIL-10R2.(19) Furthermore, a recent in vivo study
demonstrated that a preferential Th1-type inflammatory im-
mune response can be induced with malyelated antigens,
whereas a more antibody-dominated Th2 type response is ob-
served with nonmalyelated control antigens.(174) It should be
noted, however, that biologic activities of typical Th2 cytokines
have not been demonstrated to date in chicken cell culture sys-
tems. Thus, it may be argued that classic Th2-type cytokines
do not exist in birds and that cytokines with moderate Th2 char-
acteristics, such as IL-6, IL-18 and TGF-b, may downregulate
proinflammatory responses, indirectly favoring Th2-type im-
mune responses.
We assume that answers to these highly relevant questions,
as well as additional information on cytokines, cytokine re-
ceptors, and cognate cell signaling molecules, may come soon
from the application of advanced molecular techniques. EST
databases have already proved to be valuable sources of se-
quence information on chicken cytokines. Further progress
may come from studying syntenic gene loci and from sequence
information derived from the ongoing chicken genome proj-
ects.
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